OVARIAN CANCER

Cytoreductive surgery in the treatment of ovarian cancer Comprehensive Application and prospects

Foreign Medical Obstetrics and Gynecology volumes in 1999 Vol 26 No. 2

Tianjin Medical University General Hospital of Obstetrics and Gynecology (300,052) of the new QU (Summary) if Mi (revision)

Abstract <BR> since the 1980s, complete cytoreductive surgery to cisplatin-based combination chemotherapy for ovarian cancer as a conventional model, cytoreductive surgery is the complete impact of the prognosis of patients with one of the important factors for recurrent ovarian cancer once again cytoreductive surgery still some value , but to improve the survival rate of patients is more important to be effective after chemotherapy treatment as a necessary complement. Early ovarian cancer retroperitoneal lymph node dissection is reasonable and significance of the still controversial.

Tags: abdominal, age, annex, anti, bleeding, blood, cancer, cases, cause, cell, cells, chemotherapy, cisplatin, clinical, diagnosis, drug, drugs, early, eat, ert, exploration, gene, growth, incidence, increased, intraperitoneal, intravenous, life, lymph, malignant, metastasis, metastatic, method, mutation, node, ovarian, p53, patients, pelvic, physical, poor, positive, prognosis, quality, rate, reduce, resection, residual, response, second, staging, study, surgery, surgical, survival, therapy, time, toxicity, treatment, tumor, tumors

When ovarian cancer is often diagnosed late has come. As of early ovarian cancer five-year survival rate was 70% to 90%, while the terminally ill 5-year survival rate is only 20% to 30%, therefore early diagnosis is of great significance.

American researchers recently found that some symptoms can help people detect early ovarian cancer. Research on 128 patients with pelvic cancer patients and 1,709 women were studied retrospectively. Results showed that patients with malignant monthly developed symptoms 20 to 30, while patients with benign or control group of women developed symptoms two per month to three times, usually occurs in Wai menstrual cycle. More serious symptoms of patients with malignant tumors, but often in the early pathogenesis. In addition, the combination of symptoms is very important, 43% of the cancer patients while bloating, abdominal circumference and increased urinary symptoms, and the control group while the combination of these symptoms only 8%.

Tags: abdominal, benign, body, cancer, care, cause, diagnosis, early, eat, ert, examination, fat, gene, group, increased, malignant, ovarian, pain, patients, pelvic, rate, study, survival, symptoms, time, treatment, tumor, tumors, usually, women

Diagnosis
Not obvious early symptoms of ovarian cancer, so early diagnosis depends on the regular census.

1. Past history should be asked whether particular pelvic mass or the recent history of tumor growth. Women over 40 years of age and unexplained gastrointestinal symptoms, and should be gynecological examinations.
2. Body check, can be found abdominal mass, ascites positive sign.
3. Gynecological examinations beside mass, although it is solid or cystic, irregular activities of the poor, and often bilateral. Triple consultation found dome nodule or mass.
4. Auxiliary

Tags: abdominal, age, anti, benign, body, cancer, carcinoma, cell, cells, cyst, cystic, diagnosis, early, examination, growth, gynecological, history, increased, malignant, mass, ovarian, pelvic, poor, positive, protein, symptoms, tumor, women

Swedish experts recently warned that, for those with breast or ovarian cancer family history of the young women, if they have been diagnosed with breast cancer, then their risk of ovarian cancer risk would be significantly increased by 10 times. So even the experts recommended that certain breast cancer patients may be necessary for the prevention of suffering from such as ovarian cancer
Preventive measures. Kjell Bergfeldt Karolinska Institute, Doctor of Medicine, in its study of more than 30,000 cases compared 70 patients with breast cancer under the age of the medical records, and also whether their immediate family members with breast cancer or ovarian cancer cases were investigated. The results showed that if their mothers, sisters or daughters of people with breast cancer or ovarian cancer, who before the age of 40 was diagnosed with breast cancer before the age of 70 women with ovarian cancer risk will increase six-fold and 17-fold. Relevant experts believe that the discovery confirmed the existence of two types of cancer among some related links. Previous studies have already noted, carrying the BRCA1 or BRCA2 gene mutations in breast cancer patients with about 40% of people will be suffering from ovarian cancer.

Tags: age, brca1, breast, cancer, cases, ert, family, gene, history, increased, mutation, ovarian, patients, preventive, risk, study, time, women

Ovarian cancer is common gynecologic cancer, female genital tumors about 1 / 3. Can occur at any age, and women with reproductive seen. The incidence of ovarian cancer is women's genital cancer Habitat third place, as early diagnosis difficult, often found at the already advanced, but the mortality rate for the first gynecologic malignancies.
[Diagnosis]

A Symptoms

(1) abdominal discomfort or medium sized benign tumor rapid growth often cause bloating and discomfort.

(2) abdominal mass benign swelling growth slow, difficult to be discovered, patients are often inadvertently touched. Malignant tumors grow fast, easily detected.

Tags: abdominal, age, anti, benign, bleeding, blood, cancer, carcinoma, cause, cell, cells, cyst, cystic, diagnosis, early, eat, ert, estrogen, examination, gene, growth, incidence, increased, lymph, malignant, mass, metastasis, metastatic, node, oppression, ovarian, ovary, pain, patients, pelvic, positive, rate, reduce, surface, symptoms, tumor, tumors, uterine, women

[Summary]

Ovarian cancer is a common cancer of female genital mutilation one of the incidence of cervical cancer and after cancer of the uterus, which ranked third. But ovarian cancer death, accounts of the first gynecologic tumors, right pose a serious threat to women's lives. Because ovarian embryonic development, organization anatomy and endocrine function more complicated, it may be suffering from benign tumors or malignant. Because of early ovarian cancer in asymptomatic, and the identification of its type benign and malignant very difficult, ovarian carcinoma laparotomy in ovarian tumor confined to only 30%, most have spread to the uterus, bilateral annex, the omentum and pelvic organs, both in the diagnosis of ovarian cancer and governance the treatment is a major problem indeed. Over the years experts on the pathological form of ovarian cancer, the development of clinical and treatment programs for many of accumulated a lot of experience, so far, statistics on domestic and foreign clinical data, the five-year survival rate of only 25% to 30%.

Tags: abdominal, age, amenorrhea, annex, anti, benign, bleeding, blood, body, cancer, carcinoma, care, cases, cause, cell, cells, chemotherapy, clinical, cyst, cystic, days, diagnosis, dose, drug, drugs, early, eat, ert, estrogen, examination, exploration, gene, grams, growth, gynecological, history, incidence, increased, injection, intraperitoneal, intravenous, irradiation, life, lymph, malignant, mass, metastasis, method, node, oppression, ovarian, ovary, pain, patients, pelvic, poor, prognosis, protein, radiation, radiotherapy, rate, reduce, resection, residual, screening, staging, surface, surgery, surgical, survival, symptoms, syndrome, therapy, time, toxicity, treatment, tumor, tumors, uterine, women

Breast cancer screening time <BR> <BR> that breast cancer screening, women will think about breast self-examination. To promote breast self-examination has some significance to the advancement of women on the importance of breast health. But if not taught women how to correctly implemented, it is very dangerous. The American Cancer Medicine will not touch themselves, worries that if women should consult their doctors. Many studies have found that women can correct implementation of breast self-examination rate is not high, the United States is only about 32%.

Tags: abdominal, age, blood, body, breast, cancer, cause, cell, clinical, days, diagnosis, early, eat, ert, examination, family, gene, history, incidence, increased, life, lymph, metastasis, method, node, ovarian, pain, patients, rate, risk, screening, second, study, survival, time, treatment, tumor, tumors, usually, women

(1) B - ultrasound imaging can detect tumor location, size, shape and nature.

(2) radiology diagnostic barium contrast barium enema or air contrast to know whether gastrointestinal tumors. CT of pelvic tumors can locate and identify and understand the liver, lung and retroperitoneal lymph node metastasis there. Contrast pelvic lymph nodes can be judged without milk ovarian tumor lymphatic metastasis.

(3) laparoscopy can be directly observed tumor sources and generally, and the entire basin and transverse abdominal separated, and to determine the scope of other diseases. Ascites and lessons for cytology, or from dubious organizations for pathological examination. However, the enormous mass or tumor adhesion taboo.

Tags: abdominal, age, anti, cancer, carcinoma, cell, cells, cyst, cystic, diagnosis, early, eat, ert, examination, gene, increased, lymph, mass, metastasis, node, ovarian, ovary, patients, pelvic, positive, rate, reduce, tumor, tumors, women

Kikuchi, the Japanese report, have received platinum multidrug chemotherapy for recurrent ovarian cancer Japanese women, a weekly carboplatin and paclitaxel chemotherapy in a meeting, can significantly prolong survival, and patients can be tolerated. (Int J Cancer YORK 2005,15:45)

The case control study included surgery and platinum-based adjuvant chemotherapy complete remission for at least 6 months after the recurrence of ovarian cancer patients. Of the 68 patients, 27 patients received a weekly meeting of Taxol and carboplatin chemotherapy (WTJ) (Group I), carboplatin (AUC area under the curve for 2) plus paclitaxel (80 mg/m2); The remaining 41 patients (Group II) to platinum-based (P ) other chemotherapy, 37 patients with CAP program, a monthly meeting of carboplatin and paclitaxel program four cases.

Tags: cancer, carboplatin, cases, chemotherapy, clinical, drug, drugs, eat, family, gene, group, growth, increased, intraperitoneal, method, ovarian, ovary, p53, paclitaxel, patients, preventive, prognosis, protein, rate, risk, screening, second, study, surgery, survival, syndrome, taxol, therapy, time, treatment, women

Ovarian cancer is the female reproductive system cancer one of the three, as misprision of clinical symptoms, the lack of an effective method for early diagnosis, over 80% of patients had treatment for late mortality gynecologic malignancies in the first place. CA-125 tumor marker specificity is not strong, there false positive, we can not separate screening for ovarian cancer. High-throughput protein groups for the study of information technology and biological tools for ovarian cancer biomarkers of mass rapid screening provided a powerful weapon.

Tags: age, anti, benign, blood, body, cancer, cases, cell, cells, clinical, diagnosis, early, eat, eggs, gene, group, groups, increased, malignant, mass, method, ovarian, patients, positive, prostasin, protein, rate, screening, study, surgery, symptoms, treatment, tumor, tumors